Fertility Testing Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2027

ID: VPR/HC/193 Publishing Year: January 2021 Pages: 62 Format:   


Market Overview:

The Fertility Testing Market was valued at $XXX billion in2019, and it is expected to reach $XXX billion by 2027, registering a CAGR of XX% from 2021 to 2027. Fertility Testing kits comprise components which qualitatively identify the presence of reproductive hormones such as human chorionic gonadotropin , Luteinising hormone (LH) and follicle stimulating hormone (FSH). These kits help find the precise day of ovulation for women. Moreover, these kits help to confirm the presence of menopause in women, as well as it helps to detect the sperm count in males. Infertility in women is caused due increased body weight, hormone imbalance, blocked fallopian tubes, endometriosis and others, and male infertility is caused due to low sperm production, abnormal sperm function. Illnesses, injuries, chronic health problems, lifestyle choices and other factors therefore Fertility Testing is important. The increasing rate of first-time pregnancy age, declining fertility, and the launch of advanced fertility monitors with high precision are likely to be one of the reasons for the growth of the market.
Segment Overview:

Growth in the Fertility Testing Market can be caused due to factors like increasing first-time pregnancy age in women, declining fertility rate among men and women, increasing number of women suffering from disorders such as PCOS and PCOD, and increased awareness of fertility testing. However, the unverified precision of urine-based ovulation monitors in women suffering from PCOS and PCOD are the reasons that are expected to restrict market growth.

The Fertility Testing Market is segmented by Product, Mode of purchase, application, end user and region.

Product Insights:

On the basis of product insights, the market can be segmented as Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based). The ovulation predictor kits are expected to have the largest share in the Fertility Testing Market. The larger share can be attributed to low cost and high efficacy, high preference for these kits.

Purchase Insights:

The purchase insight of the Fertility Testing Market is divided into two segments prescription-based and non-prescription/OTC-based. The market for OTC or non-prescription based segment is expected to register high growth rate. Growing initiatives by key players to provide user-friendly and correct products is also expected to generate opportunities for the product. Moreover, benefits provided by the product such as easy accessibility of test results, confidentiality and e-commerce availability are also expected increase growth of the market.

Application Insights:

Based on application insight, the Fertility Test Market is divided into female Fertility Testing and male Fertility Testing. The female Fertility Testing is expected to register a larger share of the Fertility Test Market.

End User Insight:

The Fertility Test Market, by end user insight, is divided into home care setting, hospitals, fertility clinics, and others. The home care settings segment is expected for the largest share of the Fertility Test Market.

Key Segments of Fertility Testing Market:

By Product:

  • Ovulation Predictor Kits
  • Fertility Monitors (Urine & Saliva-based)

By Purchase

  • Prescription-Based
  • Non-Prescription/OTC-based

 

By Application Insights

  • Female Fertility Testing
  • Male Fertility Testing

By End User

  • Home Care Setting
  • Hospitals
  • Fertility Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

TABLE OF CONTENTS:

CHAPTER 1 MARKET INTRODUCTION

1.1. REPORT OVERVIEW

1.2. SCOPE OF THE STUDY

1.3. PRIMARY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

2.1. C-LEVEL EXECUTIVE’S OVERVIEW AND PERSPECTIVES

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. PRINCIPAL FINDINGS

3.2.1. Key investment pockets

3.2.2. Leading winning strategies

  3.2.3 Key Player Positioning

3.3. PORTERS FIVE FORCES OF COMPETITIVE ANALYSIS

 3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.4.4. Impact Analysis

3.5. IMPACT OF COVID-19 ON THIS MARKET

CHAPTER 4 Fertility testing market, BY Product

4.1. SYNOPSIS

4.1.1. Market size and forecast

4.2. Ovulation Predictor Kits

4.2.1. Key market trends

4.2.2. Growth factors and opportunities

4.2.3. Market size and forecast

4.3. Fertility Monitors (Urine & Saliva-based)

4.3.1. Key market trends

4.3.2. Growth factors and opportunities

4.3.3. Market size and forecast

CHAPTER 5 Fertility testing market, BY Purchase

5.1. Synopsis

5.1.1. Market size and forecast

5.2. Non-prescription/OTC-based

5.2.1. Key market trends

5.2.2. Growth factors and opportunities

5.2.3. Market size and forecast

5.3. Prescription based

5.3.1. Key market trends

5.3.2. Growth factors and opportunities

5.3.3. Market size and forecast  

CHAPTER 6 Fertility testing MARKET, BY Application

6.1. Synopsis

6.1.1. Market size and forecast

6.2. Male fertility testing

6.2.1. Key market trends

6.2.2. Growth factors and opportunities

6.2.3. Market size and forecast

6.3. Female fertility testing

6.3.1. Key market trends

6.3.2. Growth factors and opportunities

6.3.3. Market size and forecast

CHAPTER 7 Fertility testing market, BY End User

7.1. SYNOPSIS

7.1.1. Market size and forecast

7.2. Home care setting

7.2.1. Key market trends

7.2.2. Growth factors and opportunities

7.2.3. Market size and forecast

7.3. Hospitals

7.3.1. Key market trends

7.3.2. Growth factors and opportunities

7.3.3. Market size and forecast

7.4. Fertility clinics

7.4.1. Key market trends

7.4.2. Growth factors and opportunities

7.4.3. Market size and forecast

 CHAPTER 8 fertility testing market, BY REGION

8.1 SYNOPSIS

  8.1.1. Market size and forecast

8.2 North America

8.2.1 Key market trends

8.2.2 Competitive scenario

8.2.3 Key growth factors and opportunities

8.2.4 Market size and forecast

8.3 Europe

8.3.1 Key market trends

8.3.2 Competitive scenario

8.3.3 Key growth factors and opportunities

8.3.4 Market size and forecast

8.4 Asia Pacific

8.4.1 Key market trends

8.4.2 Competitive scenario

8.4.3 Key growth factors and opportunities

8.4.4 Market size and forecast

8.5 LAMEA

8.5.1 Key market trends

8.5.2 Key growth factors and opportunities

8.5.3 Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. Prestige Brands Holdings

9.1.1. Company overview

9.2.2. Company snapshot

9.1.3. Product portfolio

9.1.4. Business performance

9.1.5. Key strategic moves and developments

9.2 .Inc. (Prestige Brands Holdings) (U.S)

9.2.1. Company overview

9.2.2. Company snapshot

9.2.3. Operating business segments

9.2.4. Product portfolio

9.2.5. Business performance

9.2.6. Key strategic moves and developments

9.3. Hilin Life Products

9.3.1. Company overview

9.3.2. Company snapshot

9.3.3. Operating business segments

9.3.4. Product portfolio

9.3.5. Business performance

9.3.6. Key strategic moves and developments

9.4. Inc. (Hilin Life) (US)

9.4.1. Company overview

9.4.2. Company snapshot

9.4.3. Operating business segments

9.4.4. Product portfolio

9.4.5. Business performance

9.4.6. Key strategic moves and developments

9.5. Fairhaven Health

9.5.1. Company overview

9.5.2. Company snapshot

9.5.3. Operating business segments

9.5.4. Product portfolio

9.5.5. Business performance

9.5.6. Key strategic moves and developments

9.6.  LLC (Fairhaven Health) (U.S.)

9.6.1. Company overview

9.6.2. Company Snapshot

9.6.3. Operating business segments

9.6.4. Product portfolio

9.6.5. Business performance

9.6.6. Key strategic moves and developments

9.7. Fertility Focus Limited (Fertility Focus) (UK)

9.7.1. Company overview

9.7.2. Company snapshot

9.7.3. Operating business segments

9.7.4. Product portfolio

9.7.5. Business performance

9.7.6. Key strategic moves and developments

9.8. bioZhena Corporation (bioZhena) (US)

9.8.1. Company overview

9.8.2. Company snapshot

9.8.3. Operating business segments

9.8.4. Product portfolio

9.8.5. Business performance

9.8.6. Key strategic moves and developments

9.9. TaiDoc Technology Corporation (TaiDoc) (Taiwan)

9.9.1. Company overview

9.9.2. Company snapshot

9.9.3. Operating business segments

9.9.4. Product portfolio

9.9.5. Business performance

9.9.6. Key strategic moves and developments

9.10. UEBE Medical GmbH (UEBE Medical) (Germany)

9.10.1. Company overview

9.10.2. Company snapshot

9.10.3. Operating business segments

9.10.4. Product portfolio

9.10.5. Business performance

9.10.6. Key strategic moves and developments

9.11. AdvaCare Pharma (US)

9.11.1. Company overview

9.11.2. Company snapshot

9.11.3. Operating business segments

9.11.4. Product portfolio

9.11.5. Business performance

9.11.6. Key strategic moves and developments

9.12. Sensiia (UK)

9.12.1. Company overview

9.12.2. Company snapshot

9.12.3. Operating business segments

9.12.4. Product portfolio

9.12.5. Business performance

9.12.6. Key strategic moves and developments


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-9359194956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-9359194956 )

CONTACT EMAIL
[email protected]